Bank of New York Mellon’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.63M | Buy |
423,055
+67,354
| +19% | +$246K | ﹤0.01% | 3072 |
|
|
2026
Q1 | $1.41M | Sell |
355,701
-18,098
| -5% | -$91.2K | ﹤0.01% | 3003 |
|
|
2025
Q4 | $2.53M | Sell |
373,799
-126,869
| -25% | -$889K | ﹤0.01% | 2711 |
|
|
2025
Q3 | $3.49M | Buy |
500,668
+2,970
| +0.6% | +$20.6K | ﹤0.01% | 2527 |
|
|
2025
Q2 | $3.04M | Buy |
497,698
+2,058
| +0.4% | +$13.7K | ﹤0.01% | 2539 |
|
|
2025
Q1 | $3.77M | Sell |
495,640
-8,367
| -2% | -$69.9K | ﹤0.01% | 2368 |
|
|
2024
Q4 | $4.85M | Buy |
504,007
+3,300
| +0.7% | +$25.7K | ﹤0.01% | 2315 |
|
|
2024
Q3 | $2.96M | Buy |
500,707
+91,363
| +22% | +$605K | ﹤0.01% | 2566 |
|
|
2024
Q2 | $2.84M | Buy |
409,344
+35,107
| +9% | +$247K | ﹤0.01% | 2603 |
|
|
2024
Q1 | $2.88M | Sell |
374,237
-26,957
| -7% | -$217K | ﹤0.01% | 2574 |
|
|
2023
Q4 | $3.52M | Sell |
401,194
-23,027
| -5% | -$169K | ﹤0.01% | 2546 |
|
|
2023
Q3 | $3.09M | Buy |
424,221
+28,305
| +7% | +$211K | ﹤0.01% | 2561 |
|
|
2023
Q2 | $2.62M | Sell |
395,916
-6,721
| -2% | -$34.3K | ﹤0.01% | 2677 |
|
|
2023
Q1 | $1.37M | Sell |
402,637
-3,299
| -0.8% | -$12.8K | ﹤0.01% | 3003 |
|
|
2022
Q4 | $1.13M | Buy |
405,936
+2,601
| +0.6% | +$7.78K | ﹤0.01% | 3137 |
|
|
2022
Q3 | $1.16M | Buy |
403,335
+23,553
| +6% | +$83.7K | ﹤0.01% | 3134 |
|
|
2022
Q2 | $1.32M | Sell |
379,782
-15,553
| -4% | -$60.9K | ﹤0.01% | 3062 |
|
|
2022
Q1 | $1.86M | Sell |
395,335
-5,717
| -1% | -$28K | ﹤0.01% | 2974 |
|
|
2021
Q4 | $2.42M | Sell |
401,052
-30,953
| -7% | -$215K | ﹤0.01% | 2880 |
|
|
2021
Q3 | $2.62M | Buy |
432,005
+27,191
| +7% | +$306K | ﹤0.01% | 2840 |
|
|
2021
Q2 | $5.06M | Buy |
404,814
+269,495
| +199% | +$2.92M | ﹤0.01% | 2477 |
|
|
2021
Q1 | $1.39M | Sell |
135,319
-11,633
| -8% | -$112K | ﹤0.01% | 3142 |
|
|
2020
Q4 | $1.33M | Buy |
+146,952
| New | +$1.06M | ﹤0.01% | 3083 |
|
|
2018
Q4 | – | Sell |
-1,826,889
| Closed | -$11.3M | – | 4259 |
|
|
2018
Q3 | $11.3M | Buy |
1,826,889
+134,347
| +8% | +$607K | ﹤0.01% | 1949 |
|
|
2018
Q2 | $10.8M | Sell |
1,692,542
-19,681
| -1% | -$140K | ﹤0.01% | 1980 |
|
|
2018
Q1 | $11.9M | Buy |
1,712,223
+370,557
| +28% | +$4.31M | ﹤0.01% | 1892 |
|
|
2017
Q4 | $16.9M | Sell |
1,341,666
-14,969
| -1% | -$183K | ﹤0.01% | 1674 |
|
|
2017
Q3 | $16.1M | Buy |
1,356,635
+10,103
| +0.8% | +$150K | ﹤0.01% | 1698 |
|
|
2017
Q2 | $20.2M | Buy |
1,346,532
+22,024
| +2% | +$294K | 0.01% | 1551 |
|
|
2017
Q1 | $12.6M | Buy |
1,324,508
+28,335
| +2% | +$239K | ﹤0.01% | 1827 |
|
|
2016
Q4 | $11.5M | Sell |
1,296,173
-6,540
| -0.5% | -$58.8K | ﹤0.01% | 1880 |
|
|
2016
Q3 | $11.2M | Buy |
1,302,713
+38,952
| +3% | +$309K | ﹤0.01% | 1823 |
|
|
2016
Q2 | $10.1M | Sell |
1,263,761
-135,202
| -10% | -$1.05M | ﹤0.01% | 1843 |
|
|
2016
Q1 | $12.2M | Buy |
1,398,963
+141,203
| +11% | +$1.17M | ﹤0.01% | 1712 |
|
|
2015
Q4 | $11.8M | Sell |
1,257,760
-90,122
| -7% | -$781K | ﹤0.01% | 1743 |
|
|
2015
Q3 | $13M | Buy |
1,347,882
+114,558
| +9% | +$1.21M | ﹤0.01% | 1709 |
|
|
2015
Q2 | $14.3M | Buy |
1,233,324
+527,740
| +75% | +$5.43M | ﹤0.01% | 1736 |
|
|
2015
Q1 | $7.34M | Buy |
705,584
+9,194
| +1% | +$86.1K | ﹤0.01% | 2105 |
|
|
2014
Q4 | $8.03M | Buy |
696,390
+4,589
| +0.7% | +$45.3K | ﹤0.01% | 2044 |
|
|
2014
Q3 | $4.93M | Buy |
691,801
+28,100
| +4% | +$196K | ﹤0.01% | 2326 |
|
|
2014
Q2 | $4.71M | Buy |
663,701
+37,655
| +6% | +$220K | ﹤0.01% | 2355 |
|
|
2014
Q1 | $3.84M | Buy |
626,046
+32,390
| +5% | +$238K | ﹤0.01% | 2449 |
|
|
2013
Q4 | $5.19M | Buy |
593,656
+23,132
| +4% | +$142K | ﹤0.01% | 2270 |
|
|
2013
Q3 | $2.38M | Buy |
570,524
+59,161
| +12% | +$326K | ﹤0.01% | 2736 |
|
|
2013
Q2 | $3.61M | Buy |
+511,363
| New | +$3.57M | ﹤0.01% | 2386 |
|
Other funds holding MDXG
EWM
OAM
IP
AW
N
HCA
Bank of New York Mellon's MDXG Position: Q2 2026 in Review
Bank of New York Mellon increased its MiMedx Group (MDXG) stake by 19% in Q2 2026, buying an estimated $246K and bringing the position to 423,055 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3072.
Bank of New York Mellon first reported a position in MDXG in Q2 2013 and has held it in 45 quarters since. The position peaked at $20.2M in Q2 2017. 108 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.
- Bank of New York Mellon held 423,055 shares of MiMedx Group worth $1.63M as of Q2 2026.
- Bank of New York Mellon bought 67,354 MiMedx Group shares in Q2 2026, an estimated $246K.
- MiMedx Group made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3072 holding.
- Bank of New York Mellon first reported a position in MiMedx Group in Q2 2013 and has held it in 45 quarters since.
- Bank of New York Mellon's MiMedx Group position peaked at $20.2M in Q2 2017.
- 108 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.